⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18827576 | 0.69 | — | — | |
| SCHEMBL12744753 | 0.69 | — | — | |
| SCHEMBL1342813 | 0.69 | — | — | |
| SCHEMBL1342812 | 0.69 | — | — | |
| SCHEMBL17754742 | 0.66 | — | — | |
| SCHEMBL19204370 | 0.64 | — | — | |
| SCHEMBL12375179 | 0.64 | — | — | |
| SCHEMBL19431218 | 0.64 | — | — | |
| Vinyl Ether SCHEMBL11140944 | 0.59 | — | — | |
| SCHEMBL14007678 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9873696-B2 | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2018-01-23 | — | — | US | disclosed |
| US-20170217959-A1 | NEPRILYSIN INHIBITORS | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2017-08-03 | — | — | US | disclosed |